Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2000
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059864A1 Lta4 hydrolase inhibitors
10/12/2000WO2000059855A1 Ether compounds, compositions, and uses thereof
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000059520A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059487A2 Flupirtine in the treatment of fibromyalgia and related conditions
10/12/2000WO2000059484A2 Use of arylalkanoylpyridazines
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059469A2 Endodontic fibers and methods of use therefor
10/12/2000WO2000059468A1 Drinkable pharmaceutical solution
10/12/2000WO2000059449A2 Purine derivatives having phosphodiesterase iv inhibition activity
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000059285A2 NOVEL LACTAM INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000037037A3 Composition for treatment of burns
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000DE19915364A1 Verwendung von Arylalkanoylpyridazinen Use of Arylalkanoylpyridazinen
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369871A1 .alpha.-substituted carboxylic acid derivatives
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368493A1 Lta4 hydrolase inhibitors
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367143A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365834A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2364512A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use
10/12/2000CA2361848A1 Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1043317A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042350A1 Inducible phosphofructokinase and the warburg effect
10/11/2000EP1042342A1 53 human secreted proteins
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042317A1 New pharmaceutically active compounds
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1041994A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
10/11/2000EP1041989A1 Novel cycloalkenyl substituted compounds
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041896A2 Fat blend
10/11/2000EP0824916B1 Pranoprofen eyedrops containing organic amine
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
10/11/2000CN1269729A Composition for releiving inflamation and product thereof
10/11/2000CN1269722A Method and composition for modulating responsiveness to corticosteroids
10/11/2000CN1269715A Method and composition for treating late allergic reactions and inflammation diseases
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130226 Immunotherapeutic agents
10/10/2000US6130062 Production of proteins in host cells
10/10/2000CA2106762C Bradykinin antagonist peptides
10/10/2000CA2056421C Agent against autoimmune diseases
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058512A1 Antisense modulation of interleukin-5 signal transduction
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
1 ... 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 ... 1272